Arvanitis CD et al. |
Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption. |
2018 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:30150398
|
Field JJ et al. |
A previously undescribed tubulin binder. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25187564
|
Prota AE et al. |
A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs. |
2014 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:25114240
|
Liu C et al. |
Eradication of large colon tumor xenografts by targeted delivery of maytansinoids. |
1996 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:8710920
|
Rai SS and Wolff J |
The C terminus of beta-tubulin regulates vinblastine-induced tubulin polymerization. |
1998 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9539723
|
Yu TW et al. |
The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum. |
2002 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12060743
|
Sinha S and Jain S |
Natural products as anticancer agents. |
1994 |
Prog Drug Res |
pmid:7916160
|
Kubizek F et al. |
Status Quo in Antibody-Drug Conjugates - Can Glyco- Enzymes Solve the Current Challenges? |
2017 |
Protein Pept. Lett. |
pmid:28741467
|
Marcoux J et al. |
Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate. |
2015 |
Protein Sci. |
pmid:25694334
|
Wang L et al. |
Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry. |
2005 |
Protein Sci. |
pmid:16081651
|